108 results on '"PEARSON, J.P."'
Search Results
2. The effect of nanoparticle permeation on the bulk rheological properties of mucus from the small intestine
3. Targeting Allograft Injury and Inflammation in the Management of Post-Lung Transplant Bronchiolitis Obliterans Syndrome
4. MUC1 expression in primary breast cancer: the effect of tamoxifen treatment
5. STOMACH | Structure and Function
6. THE BLADDER DOES NOT APPEAR TO HAVE A DYNAMIC SECRETED CONTINUOUS MUCOUS GEL LAYER
7. The effect of dietary fibre intake on mucus secretion in the rat colon
8. Mucin genes in the GI tract
9. GASTROINTESTINAL TRACT | Structure and Function of the Stomach
10. Characterization of Escherichia Coli Strains Causing Urinary Tract Infections in Patients With Transposed Intestinal Segments
11. REDUCING MUCUS PRODUCTION AFTER URINARY RECONSTRUCTION: A PROSPECTIVE RANDOMIZED TRIAL
12. Esophageal mucin: an adherent mucus gel barrier is absent in the normal esophagus but present in columnar-lined Barrett’s esophagus
13. Human cartilage proteoglycans as T cell autoantigens
14. Longitudinal changes in gastro-oesophageal reflux from 3 months to 6 months after lung transplantation
15. MUCIN GENE EXPRESSION IN HUMAN UROTHELIUM AND IN INTESTINAL SEGMENTS TRANSPOSED INTO THE URINARY TRACT
16. Pepsin like activity in bronchoalveolar lavage fluid is suggestive of gastric aspiration in lung allografts
17. THICKNESS AND CONTINUITY OF THE HUMAN COLONIC MUCUS LAYER IS DECREASED IN ACTIVE UC BUT REMAINS NORMAL IN QUIESCENT UC
18. RHEOLOGICAL STUDIES OF BREAKDOWN AND REFORMATION OF GASTRIC MUCUS GEL DEMONSTRATES ITS UNIQUE FLOW PROPERTIES WHICH ARE ESSENTIAL TO THE MAINTENANCE OF AN INTACT PROTECTIVE BARRIER
19. 29 Ivacaftor treatment is associated with a decline in symptoms of extra-oesophageal reflux in patients with cystic fibrosis and the G551D mutation
20. Presentation of the candidate rheumatoid arthritis autoantigen aggrecan by antigen-specific B cells induces enhanced CD4+ T helper type 1 subset differentiation
21. From gastric aspiration to airway inflammation
22. THE STRUCTURE AND PROPERTIES OF GASTRIC MUCUS
23. Presentation of the candidate rheumatoid arthritis autoantigen aggrecan by antigen-specific B cells induces enhanced CD4+ T helper type 1 subset differentiation
24. WS3.1 Gastric aspiration into the CF lung – relationship with reflux symptoms and lung function
25. 117: Aspiration in the Immediate Post Lung Transplantation Period
26. 178: Does Pepsin in Gastric Juice Aspirated into the Lung Allograft Stimulate Mucus Hypersecretion?
27. Is otitis media with effusion a biofilm infection?
28. Effect of nitric oxide donation on mucin production in vitro
29. Influence of prednisolone on the secretion of mucin from the HT29-MTX cell line
30. RE: MUCIN GENE EXPRESSION IN HUMAN UROTHELIUM AND IN INTESTINAL SEGMENTS TRANSPOSED INTO THE URINARY TRACT
31. Mucosal protective effects of ecabet sodium: pepsin inhibition and interaction with mucus
32. The influence of prednisolone on the secretion of MUC5AC from TH29-MTX cell culture
33. The aetiology of otitis media with effusion: a review
34. Does the bacterial DNA found in middle ear effusions come from viable bacteria?
35. Mucin Gene Expression in Nasal Polyps: Does Transcription Always Lead to Translation?
36. Could the discontinuous and structurally weaker colonic mucus gel in ulcerative colitis be a result of free radical damage?
37. Increased serine dependent proteinases in ulcerative colitis: mucolysis and inhibition by diosmectite
38. The Use of Wheat Germ Agglutinin to Improve Binding of Heterogeneous Mucin Species to Nitrocellulose Membranes
39. Seasonal Partitioning of Leaf and Fruit Potassium and Fruit Dry Matter in French Prune Trees at Various Potassium Levels
40. Economics of mini-combined heat and power packages for use in hotels
41. Mucolytic Activity of Human Pepsins 1 and 3
42. The Carbohydrate Component of Human Pepsin 1
43. MUCOLYTIC AGENTS FOR GLUE EAR
44. The Ability of Pepsins to Degrade Gastroduodenal Mucus Glycoproteins
45. Characterization of human middle ear mucus glycoprotein in chronic secretory otitis media (CSOM)
46. Cutaneous malignant melanotic neurocristic tumors arising in neurocristic hamartomas: a melanocytic tumor morphologically and biologically distinct from common melanoma
47. DIETARY FIBRE MODULATES THE PROTECTIVE POTENTIAL OF THE COLONIC MUCOUS BARRIER AND MUCOSAL HEALTH.
48. COLONIC MICROFLORA METABOLITES ALTER THE PROTECTIVE CAPACITY OF THE COLONIC MUCUS LAYER IN VIVO.
49. Active pepsin in alrway secretions: Possible evidence for new supraesophageal pH criteria
50. STOMACH | Structure and Function
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.